Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent
Imanol Otaegui Irurueta, Sílvia González Sucarrats, Jose Luis Barrón Molina, Armando Pérez de Prado, Mònica Massotti, María Ángeles Carmona, Gerard Martí, Neus Bellera, Bernat Serra, Vicenç Serra, Enric Domingo, María López-Benito, Manuel Sabaté, Ignacio Ferreira González, Bruno García del Blanco
Topics & Concepts
MedicineStentSirolimusTarget lesionProbucolMyocardial infarctionConventional PCIRandomized controlled trialClinical endpointSurgeryRadiologyCardiologyInternal medicinePercutaneous coronary interventionCholesterolCoronary Interventions and DiagnosticsPeripheral Artery Disease ManagementCardiac Valve Diseases and Treatments